We would like to thank the below sponsors for their commitment and support.
Eli Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn.
For questions on the corporate boilerplate, please contact COMMUNICATIONS_CORPORATE@lilly.com.
Grünenthal
Medoc Ltd.
Medtronic
Metrion
MRC Systems GmbH
MYNERVA
Vertanical
Vertex Pharmaceuticals Incorporated
Vertex, a global biotechnology company, invests in scientific innovation to create transformative medicines for people with serious diseases. It has developed approved medicines that treat the underlying cause of cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain (U.S. FDA approved). Vertex also has a broad and deep clinical pipeline across a range of modalities for other serious diseases, including type 1 diabetes, APOL1-mediated kidney disease, and IgA nephropathy.
Connect with us on
Viatris
Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life’s moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris.
Connect with us on